BioAge Labs, Inc. (BIOA) Balance Sheet
As of 2026-06-30 (10-Q), BioAge Labs, Inc. (BIOA) reported total assets of $396.9M, total liabilities of $22.0M and shareholders' equity of $374.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $74.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BIOABioAge Labs, Inc.Follow BIOA — free
—
Price chart with a free account
- Market cap
- 234.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|
| Cash and equivalents | 354.3 | 188.9 | 74.0 | |
| Short-term investments | 0.0 | 92.2 | 244.8 | |
| Receivables | 0.0 | 0.8 | 0.6 | |
| Current assets | 357.1 | 286.8 | 330.3 | |
| Total assets | 358.2 | 294.9 | 396.9 | |
| Current liabilities | 27.8 | 20.1 | 19.2 | |
| Long-term debt | 2.5 | 0.0 | — | |
| Short-term debt | 6.0 | 2.6 | 0.0 | |
| Total liabilities | 35.1 | 22.8 | 22.0 | |
| Shareholders' equity | 323.1 | 272.1 | 374.9 |
USD millions · SEC XBRL
BioAge Labs, Inc. — questions
- How much cash does BioAge Labs, Inc. have?
- $74.0M in cash and cash equivalents as of 2026-06-30.
- How much debt does BioAge Labs, Inc. have?
- $0 due within a year as of 2026-06-30.
- What are BioAge Labs, Inc.'s total assets?
- $396.9M as of 2026-06-30.
- What is BioAge Labs, Inc.'s shareholders' equity?
- $374.9M as of 2026-06-30.
Every figure on this page comes from BioAge Labs, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.